Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12622000625774Phase 4Completed
Phase 4, open-label trial of morphine, fentanyl, bupivacaine, lidocaine and epinephrine in postoperative pain (2 arms), sponsored by Alfred Health. Primary endpoints: Recruitment feasibility and Protocol delivery feasibility. Started Oct 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12622000625774.